[Influence of various drugs on tissue permeability. (4)].
D000614:Aminocaproates / Q000494:pharmacology*; D000632:Aminopyrine / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001463:Barbiturates / Q000494:pharmacology; D002738:Chloroquine / Q000494:pharmacology*; D002918:Chymotrypsin / Q000037:antagonists & inhibitors / Q000494:pharmacology; D004396:Coloring Agents; D003238:Connective Tissue / Q000187:drug effects; D003501:Cyclizine / Q000494:pharmacology; D003509:Cyclohexanecarboxylic Acids / Q000494:pharmacology; D003533:Cyproheptadine / Q000494:pharmacology; D003907:Dexamethasone / Q000494:pharmacology; D004155:Diphenhydramine / Q000494:pharmacology; D005439:Flufenamic Acid / Q000494:pharmacology; D005938:Glucocorticoids / Q000494:pharmacology*; D006632:Histamine / Q000494:pharmacology; D006633:Histamine Antagonists; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006821:Hyaluronoglucosaminidase / Q000037:antagonists & inhibitors / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D010447:Peptide Hydrolases / Q000494:pharmacology; D010539:Permeability; D010653:Phenylbutazone / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D011239:Prednisolone / Q000494:pharmacology; D011480:Protease Inhibitors; D051381:Rats; D012459:Salicylates / Q000494:pharmacology
D000614:Aminocaproates; D000893:Anti-Inflammatory Agents; D001463:Barbiturates; D004396:Coloring Agents; D003509:Cyclohexanecarboxylic Acids; D005938:Glucocorticoids; D006633:Histamine Antagonists; D006634:Histamine H1 Antagonists; D010879:Piperazines; D011480:Protease Inhibitors; D012459:Salicylates; D000632:Aminopyrine; D003533:Cyproheptadine; D005439:Flufenamic Acid; D003907:Dexamethasone; D006632:Histamine; D002738:Chloroquine; D004155:Diphenhydramine; D011239:Prednisolone; D006821:Hyaluronoglucosaminidase; D010447:Peptide Hydrolases; D002918:Chymotrypsin; D010653:Phenylbutazone; D003501:Cyclizine; D007213:Indomethacin